Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
Patients with autoimmune disorders often have low levels of 25-hydroxyvitamin D [25(OH)D3], which correlates with disability or disease activity. Vitamin D may play a role in neuromyelitis optica (NMO) or NMO spectrum disorder (NMOSD), as an important factor involved in immunological pathways. We in...
Guardado en:
Autores principales: | Ju-Hong Min, Patrick Waters, Angela Vincent, Hye-Jin Cho, Byung-Euk Joo, Sook-Young Woo, Soo-Youn Lee, Hee-Young Shin, Kwang Ho Lee, Byoung Joon Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3d1bd32f0ec44c0b2f5a00fbd137763 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder
por: Su-Hyun Kim, et al.
Publicado: (2017) -
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
por: Bo Chen, et al.
Publicado: (2017) -
Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer
por: Yuan J, et al.
Publicado: (2019) -
Simultaneous new onset of neuromyelitis optica spectrum disorder in identical twins
por: Ivo Bekavac, et al.
Publicado: (2021) -
Area postrema syndrome in neuromyelitis optica spectrum disorder: diagnostic challenges and descriptive patterns
por: Eman M. Khedr, et al.
Publicado: (2021)